Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၁.၄၅%
၁,၀၈၂.၈၀
+၁၅.၄၄
+၁.၄၅%
၁,၀၆၇.၃၆၁,၀၇၃.၆၃၁,၀၈၅.၉၄၁,၀၇၃.၆၃
SIXC
Communications
SIXC
Communications
SIXC
+၀.၀၅%
၆၀၃.၇၇
+၀.၂၉
+၀.၀၅%
၆၀၃.၄၈၆၀၃.၄၈၆၀၆.၄၇၆၀၁.၄၃
SIXE
Energy
SIXE
Energy
SIXE
-၂.၇၁%
၁,၂၁၁.၁၉
-၃၃.၇၄
-၂.၇၁%
၁,၂၄၄.၉၃၁,၂၃၈.၁၀၁,၂၄၆.၅၉၁,၂၁၀.၉၄
SIXI
Industrials
SIXI
Industrials
SIXI
+၁.၄၈%
၁,၇၅၅.၉၉
+၂၅.၆၁
+၁.၄၈%
၁,၇၃၀.၃၈၁,၇၃၇.၃၀၁,၇၆၀.၆၂၁,၇၃၇.၃၀
SIXM
Financials
SIXM
Financials
SIXM
-၀.၁၅%
၆၃၈.၅၁
-၀.၉၆
-၀.၁၅%
၆၃၉.၄၇၆၃၉.၄၆၆၄၃.၀၁၆၃၆.၉၁
SIXR
Staples
SIXR
Staples
SIXR
-၁.၄၀%
၈၄၂.၉၆
-၁၁.၉၉
-၁.၄၀%
၈၅၄.၉၅၈၅၄.၉၇၈၅၅.၆၆၈၄၂.၁၃
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၀.၃၃%
၂၁၉.၂၈
+၀.၇၂
+၀.၃၃%
၂၁၈.၅၆၂၁၈.၅၆၂၂၀.၁၆၂၁၈.၅၃
SIXT
Technology
SIXT
Technology
SIXT
+၂.၆၆%
၃,၇၂၈.၃၅
+၉၆.၇၆
+၂.၆၆%
၃,၆၃၁.၅၉၃,၆၈၇.၉၈၃,၇၄၄.၃၇၃,၆၇၅.၇၁
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၀၃%
၉၁၅.၄၈
-၀.၂၉
-၀.၀၃%
၉၁၅.၇၇၉၁၇.၈၇၉၂၁.၁၆၉၁၅.၃၅
SIXV
Health care
SIXV
Health care
SIXV
-၁.၀၂%
၁,၄၉၇.၃၆
-၁၅.၄၅
-၁.၀၂%
၁,၅၁၂.၈၁၁,၅၁၄.၅၆၁,၅၁၄.၉၅၁,၄၉၇.၃၆
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၁%
၂,၄၁၃.၁၇
+၄.၉၆
+၀.၂၁%
၂,၄၀၈.၂၁၂,၄၁၈.၁၁၂,၄၂၇.၂၃၂,၃၉၈.၁၆
ERF:EPA
Eurofins Scientific SE
၆၁.၉၆ €
-၂.၀၂%
(-၁.၂၈) 1D
မေ ၂၆, GMT+၂ ၁၇:၃၅:၂၉  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ERF...
Open
၆၂.၆၆ €
High
၆၃.၀၂ €
Low
၆၁.၉၆ €
Mkt. cap
ဋေ ၁.၁၀ ထ
Avg. vol.
၃.၂၉ သိန်း
Volume
၂.၁၂ သိန်း
P/E ratio
၂၈.၂၀
52-wk high
၇၄.၃၂ €
52-wk low
၅၄.၈၆ €
EPS
၂.၂၀ €
Shares outstanding
၁၇.၆၀ ကုဋေ
No. of employees
၇ သောင်း
News stories
From sources across the web
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Eurofins Scientific SE stock (FR0014000MR3): lab specialist in focus after recent news
Profile
Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments. Eurofins Group has an international network of over 900 laboratories in 62 countries and a portfolio of over 200,000 validated analytical methods for characterizing the safety, identity, purity, composition, authenticity and origin of products and biological substances. Eurofins also provides clinical diagnostic testing services and in-vitro diagnostic products. Wikipedia
About Eurofins Scientific SE
CEOGilles G. Martin
Employees၆.၅၇ သောင်း
Founded၁၉၈၇
Headquarters-
Sector-
Last report
၂၀၂၆ ဧ ၂၂
Fiscal period
Q1 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
၁၇၈.၉၀ ဋေ / ၁၈၂.၃၀ ဋေ
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၁၈၀.၆၀ ဋေ
၁၈၀.၆၀ ဋေ
၁၈၄.၂၀ ဋေ
၁၈၄.၂၀ ဋေ
Cost of goods sold
၁၄၀.၀၉ ဋေ
၁၄၀.၀၉ ဋေ
၁၄၂.၆၇ ဋေ
၁၄၂.၆၇ ဋေ
Cost of revenue
၁၄၀.၀၉ ဋေ
၁၄၀.၀၉ ဋေ
၁၄၂.၆၇ ဋေ
၁၄၂.၆၇ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
၁.၀၅ သန်း
၁.၀၅ သန်း
Operating expense
၁၆.၇၄ ကုဋေ
၁၆.၇၄ ကုဋေ
၁၇.၁၂ ကုဋေ
၁၇.၁၂ ကုဋေ
Total operating expenses
၁၅၆.၈၃ ဋေ
၁၅၆.၈၃ ဋေ
၁၅၉.၇၉ ဋေ
၁၅၉.၇၉ ဋေ
Operating income
၂၃.၇၇ ကုဋေ
၂၃.၇၇ ကုဋေ
၂၄.၄၂ ကုဋေ
၂၄.၄၂ ကုဋေ
Other non operating income
-၁.၅၀ သန်း
-၁.၅၀ သန်း
၁.၈၅ သန်း
၁.၈၅ သန်း
EBT including unusual items
၁၇.၃၂ ကုဋေ
၁၇.၃၂ ကုဋေ
၁၅.၃၉ ကုဋေ
၁၅.၃၉ ကုဋေ
EBT excluding unusual items
၂၁.၁၀ ကုဋေ
၂၁.၁၀ ကုဋေ
၂၀.၆၇ ကုဋေ
၂၀.၆၇ ကုဋေ
Income tax expense
၄.၉၈ ကုဋေ
၄.၉၈ ကုဋေ
၄.၀၇ ကုဋေ
၄.၀၇ ကုဋေ
Effective tax rate
၂၈.၇၉%
၂၈.၇၉%
၂၆.၄၅%
၂၆.၄၅%
Other operating expenses
-
-
-
-
Net income
၁၂.၃၃ ကုဋေ
၁၂.၃၃ ကုဋေ
၁၁.၄၁ ကုဋေ
၁၁.၄၁ ကုဋေ
Net profit margin
၆.၈၃%
၆.၈၃%
၆.၁၉%
၆.၁၉%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-၃.၅၄ ကုဋေ
-၃.၅၄ ကုဋေ
-၄.၁၆ ကုဋေ
-၄.၁၆ ကုဋေ
Net interest expenses
-၃.၅၄ ကုဋေ
-၃.၅၄ ကုဋေ
-၄.၁၆ ကုဋေ
-၄.၁၆ ကုဋေ
Depreciation and amortization charges
၁၃.၉၅ ကုဋေ
၁၃.၉၅ ကုဋေ
၁၄.၁၄ ကုဋေ
၁၄.၁၄ ကုဋေ
EBITDA
၄၀.၈၈ ကုဋေ
၄၀.၈၈ ကုဋေ
၃၁.၈၈ ကုဋေ
၃၁.၈၈ ကုဋေ
Gain or loss from assets sale
၁.၁၅ သန်း
၁.၁၅ သန်း
၃.၃၀ သန်း
၃.၃၀ သန်း
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more